1 Phase 2b/3 in moderate-to severe hidradenitis Suppurative (HS) and Uveitis. Potential inclusion into registrational package for HS and Uveitis if granted orphan drug designation and following consultation with relevant health authorities.
2 Phase 2b/3 in Psoriatic Arthritis (PsA).
3 Excludes mainland China, Hong Kong, Macau, South Korea, Taiwan and certain other Asia Pacific countries.
4 Worldwide rights to non-oncology indications.
Hidradenitis suppurativa (HS) is a very painful, lifelong, and recurring skin condition that causes abscesses and scarring 1,2. Areas often affected include the groin and genitals, the armpits, areas around the anus, and below the breasts1,2.